The ability to identify individuals
who are truly infected with M. tuberculosis and who are at risk for disease will tremendously simplify the process of tuberculosis elimination in the United States.
- Institute of Medicine

Geiter L, "Ending Neglect:  The elimination of Tuberculosis in the United States", 1st ed., Washington DC:  National Academy Press 2000.

How It Works

The T-SPOT®.TB test is the cellular blood test that detects the immune response of T cells found in peripheral blood mononuclear cells (PBMC) that have been stimulated by Mycobacterium tuberculosis

The immune response to infection with Mycobacterium tuberculosis is mediated predominately through T cell activation.  As part of this response, T cells are sensitized to M. tuberculosis antigens.  Stimulated by these antigens, the activated effector T cells, both CD4+ and CD8+, produce the cytokine interferon gamma (IFN-γ).  T-SPOT.TB uses the enzyme-linked immunospot (ELISpot) methodology to enumerate M. tuberculosis-sensitized T cells by releasing interferon-gamma (IFN-γ) in the vicinity of T cells.

The T-SPOT.TB Test

  • Removes background interferon gamma to maximize sensitivity
  • Utilizes a standard number of PBMCs to correct for patient's immune status
  • Uses TB specific antigens (ESAT-6 and CFP 10) not present in BCG and most non-tuberculosis mycobacteria to prevent cross-reactivity

Performing the T-SPOT.TB test involves the following steps using standard lab equipment:



Interpretation of Results

  • Interferon gamma is captured and presented as spots from T cells sensitized to Mycobacterium tuberculosis
  • Results are interpreted by subtracting the spot count in the negative (NIL) control from the spot count in Panels A and B